Fundraising Fox

Aileron Therapeutics

NASDAQ: RNTX

Cambridge, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

MA
Manuel AivadoExecutive Officer
JH
John H. McArthurDirector
RJ
Reinhard J. AmbrosDirector
BM
Brian M. Gallagher, Jr.Director
AS
Armen ShanafeltDirector
SK
Scott KapnickDirector
CW
Caleb WinderDirector
SL
Seth L. HarrisonDirector
JA
Joseph A. Yanchik IIIExecutive Officer, Director

Investors · 1

Excel Venture ManagementreportedBoston · $1M – $5Mvia Caleb Winder · board

Reported raises · per SEC filings

Form D private placements
▶$18.3MraisedNov 2023 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan MussoDirector
  • Reinhard J. AmbrosDirector
  • Nolan Sigal, M.D., Ph.D.Director
  • William FaireyDirector
  • Josef H. von RickenbachDirector
  • Manuel Alves-Aivado, M.D., Ph.D.Executive Officer, Director
  • Brian Windsor, Ph.D.Executive Officer
  • Susan L. DrexlerExecutive Officer
Offering amount
$18.3M
Amount sold
$18.3M
Sales commissions
$752.8K
Placement agents
Arcadia Securities, LLC, Clear Street LLC
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30.1MraisedJan 2017 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Manuel AivadoExecutive Officer
  • Caleb WinderDirector
  • Seth L. HarrisonDirector
  • John H. McArthurDirector
  • Reinhard J. AmbrosDirector
  • Joseph A. Yanchik IIIExecutive Officer, Director
  • Brian M. Gallagher, Jr.Director
  • Armen ShanafeltDirector
  • Scott KapnickDirector
Offering amount
$40M
Amount sold
$30.1M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.